Market Cap

PDS Biotechnology Corporation Market Capitalization:

$114.4 Million

USD as of July 1, 2024

business PDS Biotechnology Corporation Company Profile

PDS Biotechnology Corporation Main Stock Listing

NASDAQ: PDSB

Market Capitalization History of PDS Biotechnology Corporation

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of PDS Biotechnology Corporation market cap

Date Market Cap YoY Change
Jan. 1, 2024 $156.2 M -47.21%
Jan. 1, 2023 $295.8 M 56.71%
Jan. 1, 2022 $188.8 M 95.41%
Jan. 1, 2021 $96.6 M 23.48%
Jan. 1, 2020 $78.2 M -71.93%
Jan. 1, 2019 $278.7 M -96.55%
Jan. 1, 2018 $8.07 B 32.29%
Jan. 1, 2017 $6.10 B -13.32%
Jan. 1, 2016 $7.04 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

PDS Biotechnology Corporation Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

PDS Biotechnology Corporation has the following listings and related stock indices.


Stock: NASDAQ: PDSB

Stock: FSX: EU6

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.